Key Takeaways from the CDDF Live Webinar on EU HTA Regulation (March 2025)
🔔 📢 The Cancer Drug Development Forum (CDDF) held a live webinar on “EU HTA Regulation.” on 12 March at 17:00 CET. This webinar featured a lively discussion between Michael Berntgen (EMA, NL), Niklas Hedberg (TLV, SE) and Dr. Vanessa Schaub (Roche, CH). Dr. Rosa...
Article: The Importance of Diversity in Clinical Research
[📢Article on the Importance of Diversity in Clinical Research ] Yesterday our former Board Member; John Smyth, published an interesting article on the Importance of Diversity in Clinical Research in the ASCO Post. This topic was at the heart of the discussions, which...
CDDF Job Opening – Director of Operations
[📣 🔔CDDF Job Opening - Director of Operations] The Cancer Drug Development Forum (CDDF) is seeking a dynamic and experienced Director of Operations to join our team and lead the day-to-day operations of the association. As a key member of the leadership team, the...
Key Takeaways from the Annual Conference 2025 (3-5 Feb 2025, Noordwijk aan Zee) Day 2
The second day of the CDDF Annual Conference on Challenges, Advances, and Open Questions in Global Cancer Drug Development and Clinical Trial brought together a diverse group of stakeholders into open, constructive discussions in order to improve cancer drug...
Key Takeaways from the Annual Conference 2025 (3-5 Feb 2025, Noordwijk aan Zee)
The first day of the CDDF Annual Conference on Challenges, Advances, and Open Questions in Global Cancer Drug Development and Clinical Trial brought together a diverse group of stakeholders into open, constructive discussions in order to improve cancer drug...
ACT EU workshop on ICH E6 R3 – broadcast details and Slido
Dear participants, Thank you for your interest in participating in upcoming ACT EU workshop on ICH E6 R3. Due to the high level of interest, the programme committee has decided that participants joining remotely should access the broadcast the event, accessible via...
Forwarding Information – public consultation on the ICH M15 Guideline on general principles for model-informed drug development
The European Medicines Agency has published for public consultation the ICH M15 Guideline on general principles for model-informed drug development. This guideline provides general recommendations for planning, model evaluation, and documentation of evidence derived...
ICH E6(R3) final principles & Annex 1 published
We are pleased to announce that the ICH E6(R3) principles and Annex 1 have been finalised and published on the ICH website. This is a rewrite and reorganisation of the R2 version of the guideline on Good Clinical Practice (GCP), which sets international standards for...
Launch of MSP AG consultation on clinical trials training needs for academia and SMEs | Deadline 11 February 2025 (close of business)
We are pleased to announce the launch of the ACT EU consultation on clinical trials training needs for academia and SMEs. As a reminder, the consultation stems from ACT EU initiative’s Priority Action on clinical trials training aiming to deliver a clinical trials...